Prednisone and prednisolone in rheumatoid arthritis; an evaluation of their therapeutic efficiency (Q74424860)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407235%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Prednisone and prednisolone in rheumatoid arthritis; an evaluation of their therapeutic efficiency (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407235%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

E W BOLAND

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407235%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 March 1957

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407235%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407235%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407235%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407235%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

553-564

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407235%20AND%20SRC:MED&resulttype=core&format=json

Growth-survival and sodium retaining activity of 9 alpha-halo derivatives hydrocortisone

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934454-6

Biological effects of 9-alpha-fluorohydrocortisone and related halogenated steroids in animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934454-6

Experiences with 9-alpha-fluorohydrocortisone acetate in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934454-6

Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934454-6

Metabolic effects of metacortandralone and metacortandracin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934454-6

Major undesirable side-effects resulting from prednisolone and prednisone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934454-6

Prednisone and prednisolone therapy in rheumatoid arthritis; clinical evaluation based on continuous observations for periods of six to nine months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934454-6

Hydrocortisone administered orally in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934454-6

Oral hydrocortisone in the treatment of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934454-6

Present status of hydrocortisone as a therapeutic agent in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934454-6

Effects of prednisone (meticorten) on manifestations of rheumatoid arthritis; report of early clinical observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934454-6

Prednisone and prednisolone in the treatment of systemic lupus erythematous

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934454-6

10.1016/S0025-7125(16)34454-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407235%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference